CCCC – c4 therapeutics, inc. (US:NASDAQ)
Stock Stats
News
C4 Therapeutics, Inc. (NASDAQ: CCCC) had its price target raised by analysts at Wells Fargo & Company from $7.00 to $8.00. They now have an "equal weight" rating on the stock.
C4 Therapeutics, Inc. (NASDAQ: CCCC) had its price target raised by analysts at Stifel Nicolaus from $13.00 to $14.00. They now have a "buy" rating on the stock.
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Form 10-Q C4 Therapeutics, Inc. For: Mar 31
Form 8-K C4 Therapeutics, Inc. For: May 08
Form ARS C4 Therapeutics, Inc. For: Apr 30
Form DEFA14A C4 Therapeutics, Inc.
Form DEF 14A C4 Therapeutics, Inc. For: Apr 29
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.